Skip to Content

Tag Archives: Colgate-Palmolive

October 2004 Issue & Supplement

In this month’s visit, we’ll take our strategy a step further. Among our World-Class Franchises, we’re swapping out of a lower-yielding stock into another that will double our dividend income. Plus, I’m looking for our newest selection to deliver growth of up to 60% in its share price over the next three years.

Swap Out of Colgate

Colgate-Palmolive (NYSE: CL), one of our model portfolio stocks, yesterday trimmed its earnings outlook for the second half of 2004 by about 14%. I had been mulling a swap out of the stock, but now the argument is even stronger.

STAPLES FOR SAFETY

The stock market has had a marvelous run these past nine months — no doubt about it. There’s more to come in 2004, too. But I’m growing increasingly wary about the near-term outlook (the next three or four weeks, say). The number of NYSE stocks making new 52-week highs has contracted sharply over the past two weeks, while options speculators are buying calls like mad.

MUSINGS FROM THE MADHOUSE

Wall Street is never loonier than at earnings season — as we’ve seen again today from the crowd’s reaction to the latest quarterly numbers from Colgate-Palmolive (NYSE: CL). Colgate hit its profit target perfectly, with a 10% increase in earnings per share.